Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
asymptomatic
ataxia
ataxia telangiectasia
ataxia, cerebellar
biologic markers
cerebellar ataxia, autosomal recessive
cerebellar ataxia, hereditary
cerebellar atrophy, primary
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS tumors
chemotherapy, CNS treatment and complications with
controversies in neurology
dysarthria
dysdiadochokinesia
dysmetria
electromyogram
eye movement, disorders of
Friedreich's ataxia
gait disorder
gene
gene mutation
genetic neurologic disorders
genetic testing
glioma
glioma, low-grade
hypotonia
imbalance
incoordination
leukoencephalopathy
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
molecular genetics
molecular markers
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, negative
myelomalacia
neoplasm, primary intracerebral
neoplasm, primary of CNS
neoplasm, primary of CNS-survival
neoplasm, primary of CNS-treatment of
nerve conduction studies
neurologic disease, diagnoses of
polymerase chain reaction
prognosis
radiation therapy, CNS treatment and complications with
review article
saccadic eye movements, abnormal
seizure
staggering
tandem gait, ataxic
temozolomide
treatment of neurologic disorder
tremor
tremor, cerebellar
tremor, intention
vitamin E deficiency
walking, difficulty with
white matter disease
workup
Showing articles 250 to 300 of 763 << Previous Next >>

Detection of Unknown Primary Tumor in a Patient with Cerebellar Metastasis Using FDG PET-CT: Case Report
No Shinkei Geka 34:1027-1032, Ishiguro,T.,et al, 2006

Whole-Body MRI and PET-CT in the Management of Cancer Patients
Eur Radiol 16:1216-1225, Schmidt,G.P.,et al, 2006

Phenotypic Spectrum Associated with Mutations of the Mitochondrial Polymerase y Gene
Brain 129:1674-1684, Horvath, R.,et al, 2006

Mitochondrial DNA Polymerase-y and Human Disease
Hum Mol Genet 15:R244-R252, Hudson, G.,et al, 2006

Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia
Arch Neurol 63:144-146,146, Rikkert,M.G.M.O.,et al, 2006

Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006

Clinicopath Conf, Charcot-Marie-Tooth Disease Type 2, with Aides Pupil and a Mutation in MPZ Gene
NEJM 354:2584-2592, Case 18-2006, 2006

Early Clinical Signs and Imaging Findings in Gerstmann-Straussler-Scheinker Syndrome (Pro102Leu)
Neurol 66:1672-1678, Arata,H.,et al, 2006

Clinicopath Conf, Dopamine-Responsive-Dystonia Caused by a Mutation in the GCH1 Gene
NEJM 355:831-839, Case 26-2006, 2006

Episodic Neurologic Dysfunction with Migraine and Reversible Imaging Findings After RadiationRRH
Neurol 67:676-678, Pruitt,A.,et al, 2006

Diagnosis of Neurolymphomatosis with FDG PET
Neurol 67:722-723, Rosso,S.M.,et al, 2006

Fragile X Premutation With Atypical Symptoms at Onset
Arch Neurol 63:1135-1138, Cellini,E.,et al, 2006

The Tuberous Sclerosis Complex
NEJM 355:1345-1356, Crino,P.B.,et al, 2006

PET of Brain Amyloid and Tau in Mild Cognitive Impairment
NEJM 355:2652-2663, Small,G.W.,et al, 2006

The role of radiotracer imaging in Parkinson disease
Neurol 64:208-215, Ravina, B., et al, 2005

Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
JAMA 293:427-436, The CREATE Trial Group Investigators, 2005

The Pathophysiology of Watershed Infarction in Internal Carotid Artery Disease
Stroke 36:567-577, Momjian-Mayor, I. & Baron, J-C., 2005

Unusual Variants of Alexander's Disease
Ann Neurol 57:327-338, van der Knaap,M.S., et al, 2005

A New Cause of Limbic Encephalopathy
Brain 128:1745-1746, Darnell,R.B., et al, 2005

Treatment-Responsive Limbic Encephalitis Identified by Neuropil Antibodies: MRI and PET Correlates
Brain 128:1764-1777, Ances,B.M., et al, 2005

Heparin-Induced Thrombocytopenia in Neurologic Patients Treated with Low-Molecular-Weight Heparin
Neurol 64:1285-1287, Pohl,C.,et al, 2005

Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy
Arch Neurol 62:721-728, Mega,M.S.,et al, 2005

[99mTc]TRODAT-1 SPECT Imaging Correlates with Odor Identification in Early Parkinson Disease
Neurol 64:1716-1720, Siderowf,A.,et al, 2005

High Titers of CA-125 May Be Associated weith Recurrent Ischemic Strokes in Patients with Cancer
Neurol 64:1944-1945, Jovin,T.G.,et al, 2005

A Positron Emission Tomographic Study in Spontaneous Migraine
Arch Neurol 62:1270-1275, Afridi,S.K.,et al, 2005

Lesion Size Determines Accuracy of Thallium-201 Brain Single-Photon Emission Tomography in Differentiating Between Intracranial Malignancy and Infection in AIDS Patients
AJNR 26:1973-1979, Younhg,R.J.,et al, 2005

Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma
Hematol Oncol Clin North Am 19:689-703, Fitzsimmons,A.,et al, 2005

Progressive Myoclonic Epilepsies: A Review of Genetic and Therapeutic Aspects
Lancet Neurol 4:239-248, Shahwan, A., et al, 2005

Unknown Primary Tumors: Detection with Dual-Modality PET/CT--Initial Experience
Radiology 234:227-234, Gutzeit,A.,et al, 2005

Beta2 Microglobulin as a Surrogate Marker for HIV Infection: Good Correlation with CD4 counts
Indian J Pathol Microbiol 47:298-301, Wanchu, A.,et al, 2004

Clinical and Molecular Findings in Patients with Giant Axonal Neuropathy (GAN)
Neurol 62:13-16, Bruno,C.,et al, 2004

Neuro-Ophthalmic Findings in the Visual Variant of Alzheimers Disease
Ophthalmology 111:376-381, Lee,A.G. &Martin,C.O., 2004

Neuroprotection in Parkinson Disease, Mysteries, Myths, and Misconceptions
JAMA 291:358-364, Schapira,A.H.V.&Olanow,C.W., 2004

B- and T-cell Markers in Opsoclonus-Myoclonus Syndrome
Neurol 62:1526-1532,1466, Pranzatelli,M.R.,et al, 2004

Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004

Aromatic L-Amino Acid Decarboxylase Deficiency
Neurol 62:1058-1065, Pons,R.,et al, 2004

Basal Ganglia Hyperperfusion in a Patient with Systemic Lupus Erythematosus-Related Parkinsonism
Neurol 63:395-396, Lee,P.H.,et al, 2004

Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
NEJM 350:2682-2688,2642, Schuelke,M.,et al, 2004

Idiopathic Hyposmia As a Preclinical Sign of Parkinson's Disease
Ann Neurol 56:173-181,169, Ponsen,M.M.,et al, 2004

Pathogenetic Mechanisms of Parkin in Parkinson's Disease
Lancet 364:722-724, Hattori,N. &Mizuno,Y., 2004

Serial 18F-fluoro-2-deoxy-D-glucose Positron Emmission Tomography and Magnetic Resonance Imaging of Paraneoplastic Limbic Encephalitis
Arch Neurol 61:1785-1789, Scheid,R.,et al, 2004

Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004

Anticoagulants for Acute Ischemic Stroke
Stroke 35:2916-2917, Sandercock,P.,et al, 2004

Effective Prophylaxis for Deep Vein Thrombosis After Stroke, Low-Dose Anticoagulation Rather Than Stockings Alone: Against
Stroke 35:2912-2913,2910, Dennis,M.S., 2004

Effective Prophylaxis for Deep Vein Thrombosis After Stroke, Low-Dose Angicoagulation Rather Than Stockings Alone: For
Stroke 35:2911-2912,2910, Adams,H.P., 2004

Gene Transfer for Neurologic Disease
Neurol 63:2225-2232, Mendell,J.R. &Miller,A., 2004

Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003

Practice Parameter: Evaluation of the Child with Global Developmental Delay
Neurol 60:367-380, Shevell,M.,et al, 2003

Myotonic Dystrophy Type 2
Neurol 60:657-664, Day,J.W.,et al, 2003



Showing articles 250 to 300 of 763 << Previous Next >>